MSD says the new license claim means the vaccine combines the broadest calf scour protection available with unique user convenience.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: “When correctly administered as a single 2ml intramuscular dose to pregnant cattle 12-3 weeks prior to calving, Bovilis Rotavec Corona boosts antibodies in colostrum for rotavirus, coronavirus and now both E.coli F5 (K99) and F41.
"Calves gain protection against these infectious scour pathogens by drinking the fortified colostrum from their vaccinated mothers.
“Bovilis Rotavec Corona also contains the most prevalent rotavirus strain in Europe2, which minimises the chances of a calf scour protection breakdown due to differences between vaccine antigens and the ubiquitous antigens on farm3.”
Kat added: "Vet, RAMA and farmer feedback suggests the wide vaccination window (12-3 weeks pre-calving) and the fact that an opened bottle of vaccine lasts for up to 28 days are particularly useful practical benefits in a mix of both dairy and beef suckler systems.”
Bovilis Rotavec Corona is available in 5, 20 and 50-dose packs from both veterinary professionals and the agricultural merchant trade.
References
The company, which was founded by scientists from the human field, managed to raise £8 million of Series A funding by February this year. It is now seeking further investment for an extension to that Series A funding by the autumn.
The company's Chief Scientific Officer is Professor Allan Bradley, Emeritus Director of the Wellcome Trust Sanger Institute and a Fellow of the Royal Society (pictured right). He spearheaded the development of mouse transgenics and their translational use, which provided the basis for developing canine monoclonal antibody therapies.
Allan said: "We are growing a world-class scientific team that will enable PetMedix to become a global leader in the development of novel monoclonal antibody therapies for the expanding animal health market. In the short lifetime of the company we have attracted huge talent in both our scientists and executives, and moved into the heart of the Cambridge biotech sphere with its excellent facilities and networking opportunities. The recent appointment of Dr. Fabian Kausche to the board marks our intent to become a global leader in animal health."
CEO, Dr. Tom Weaver added: "We have the people and the technology in place, and are champing at the bit to progress these therapies to reach the pets that could benefit. We know this technology has transformed the treatment and survival of human patients with a variety of conditions and we want to create the same paradigm shift in veterinary treatment options to improve welfare, quality of life and longevity for our dogs and cats."
PetMedix says it is interested in hearing from potential investment partners, and mergers and acquisitions. Contact Jolyon Martin via email: jolyon.martin@PetMedix.co.uk or telephone: +44 (0) 1223 734140,
The intranasal vaccine can be administered to calves from one week old. It reduces the clinical signs of respiratory disease and viral shedding from infection with Bovine Respiratory Syncytial Virus (BRSV) and Parainfluenza-3 Virus (Pi3V).
MSD says that no other UK-licensed BRD vaccine can be administered earlier in life, and claims the vaccine delivers the fastest on-farm protection, with an onset of immunity after administration of 5 days for BRSV and 7 days for Pi3V. Duration of immunity is 12 weeks for both viruses.
MSD Animal Health livestock veterinary adviser Dr Kat Baxter-Smith said: "Having this early life calf pneumonia vaccine available in single dose vials will give farmers more practical leeway to be able to vaccinate vulnerable young calves from as young as a week of age, rather than delaying administration until a batch of calves are available. We know that early-age protection of young calves through intranasal vaccination can help prevent pneumonia and positively impact a beef or dairy calf’s productive future".
The new single dose vials are supplied in packs of five, complementing the five dose vials already available.
For further information, contact your MSD account manager.
Invicta Animal Health has announced the launch of Ocuvance, a nutritional supplement to support ocular health in dogs and cats.
The company says Ocuvance is formulated to provide an antioxidant complex supporting and maintaining the health of eyes. The tablets contain lutein, a xanthophyll pigment found within the eye. They also contain anthocyanosides derived from bilberry extract to support rhodopsin production. The formulation also contains vitamins C and E, zinc and selenium.
Ocuvance is presented in packs of 30 scored tablets; sufficient for a one month supply for the average sized dog.
Rob Watkins, Managing Director of Invicta, said: "We are delighted to make Ocuvance available to veterinary surgeons in the UK. A recent veterinary study1 has shown there can be significant ophthalmic benefits of antioxidant supplementation.
We carefully formulated Ocuvance to provide a range of high quality ingredients to maintain normal visual function whilst still being affordable for owners”.
Ocuvance is now available from all veterinary wholesalers.
Reference
Norbrook Laboratories has launched Closamectin, a parasiticide which the company says will revolutionise cattle farming and parasite control in meat producing animals.
Closamectin Pour-on is a solution which can quite literally be poured onto the back of animals. It simultaneously treats fluke, worms and external parasites. The new product is the culmination of a six year research project costing £3.5 million and involving 80 scientists at the company's headquarters in Newry Co Down.
Norbrook says it will bring immense benefits for farmers whose cattle are often ravaged by parasitic attack. Fluke in particular can have devastating effects both on beef and dairy herds, seriously weakening, and in some cases killing the animals by destroying their livers. At the very least it collectively costs farmers around £17 million per annum by reducing the weight of beef cattle and the milk yields of dairy cows.
Fluke used to be confined to the western parts of Britain, together with Scotland and Ireland, but global warming has seen other parts of the UK experiencing the same mild and wet conditions on which the parasite thrives. Consequently it is on the rise.
Currently fluke is treated by injection or oral drench - both time-consuming and difficult processes for the farmers which can also be stressful for the animals. In contrast pour-on solutions can be applied swiftly and easily with no detrimental impact on cattle.
Norbrook has been awarded licenses for Closamectin Pour-on in both the UK and Ireland. This is a very significant market: the countries have a combined cattle population of 17 million. There are also plans to roll out the product in other countries.
Developing a pour-on to deal with these parasites has baffled scientists for 20 years. Alistair Couper, Norbrook's Chief Vet said: "This is the Holy Grail of farm animal veterinary medicine. It was a highly complex challenge for our research team. They had to develop a product which would treat different conditions simultaneously and have a molecular structure which could be absorbed straight through the skin. This is a ground breaking achievement and a brilliant piece of science"
Lord Ballyedmond, Chairman of Norbrook Laboratories said: "This is a very important milestone for Norbrook and for livestock and farmers worldwide. We have invested heavily in research and development and the results are there for all to see. We are delighted to have beaten other multinationals. We have now developed the world's most effective remedy for parasite control in cattle that our entering the food chain. I am pleased to state that our business has grown this year indigenously at 12% despite the recession, beating our competitors. This tremendous breakthrough is a great testimony to the brilliance of our scientists in Newry and also to our policy of investing in research. "
Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis, prior to invasive procedures.
Invicta says Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don't come into contact with either the contents or the patient's skin.
Rob Watkins, Managing Director of Invicta, said: "Most surgical site infections (SSI's) are the result of contamination from a patient's own skin flora1, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI's in patients."
According to the company, research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations2.
Invicta says the way in which the solution is applied to the skin is as important as the solution itself. Studies show that the most effective way to apply Chloraprep is with a back and forth scrubbing movement because this gives a lower microbial count on the skin than using other application methods3. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours4.
Rob said: "The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade."
He added: 'The veterinary nurses I've spoken to love this product, because they're fed up of immersing their dry, cracked hands in disinfectant!'
For further information, please contact Invicta Animal Health on 01403 791313 or email the company at mail@invictavet.com.
1. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61.2. Hibbard JS. J Infus Nurs 2005; 28: 194-207.3. Rosenthal K. Nurs Manage 2006; April: 55-66.4. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418.
The company says more and more CT scanners are being used in general practice, but many teams have been telling them they're not sure if they're using their scanner optimally, or that only some of the team are confident in using it.
The online training aims help teams get the best diagnostic use of CT
The first of the sessions, on 15th June, will cover the indications and benefits of CT in small animal practice.
The second on 22nd June will look at how and when to perform CT reconstructions.
Manuel Pinilla, VetCT Supporting Radiologist and Director of Quality Assurance (pictured right), will be delivering the talks.
Manuel said: “We are seeing a rapid increase in the use of CT in first opinion practice.
"We know CT can provide vital diagnostic information in addition to the more traditional modalities of x-ray and ultrasound.
"However, it can be challenging to optimise the diagnostic capability.
"We’re keen to support veterinary teams to help them get the most out of their machine and do the best for their patients and the owners.”
To register for the training, visit: https://welcome.vet-ct.com/ctcpdwebinars
The London Vet Show was a runaway success this year, with more delegates on day one than visited the entire show in 2010.
Rob Chapman from CloserStill Media, organiser of the event said: "We're still number crunching, but it looks like numbers were up something like 40% on last year."
VetSurgeon.org visited the event and filmed a number of the commercial exhibitors, many of whom said what a good atmosphere there was at the show and how busy it was.
CloserStill has already confirmed that the London Vet Show will again take place in the Grand Hall at London Olympia next year. However, it will be expanding into West Hall for the clinical lectures, so that everyone can have a seat, unlike this year when demand was so high, some had to sit on the floor.
The initiative is part of the company’s Keeping Britain’s Horses Healthy (KBHH), and provides a way that practices can work with their Equine Account Manager to help horse owners bring their vaccination status up-to-date for equine influenza and tetanus.
Peter Young, Equine Business Manager said: "We’re aware how easy it is for owners to get behind on their horses’ vaccinations but with over half of the UK horse population not protected against equine ‘flu, vets need all the help they can get to improve vaccination rates in their area. We should be aiming for at least 70% ‘flu vaccination rates to ensure our horses benefit from herd immunity so we’re offering vets some practical support to help them improve the situation."
The KBHH vaccination amnesty will be offering a reduced cost option for horses needing to restart a primary course, encouraging horse owners to add their horse to the population already protected.
Horses will need to be over 12 months of age and be unvaccinated or have lapsed from their normal booster vaccination for more than three months.
MSD is also providing a range of online and printed material for vets to help promote the amnesty and ensure their clients take action, including materials that practices can post on Facebook to raise awareness of the symptoms of equine ‘flu and the importance of vaccination.
For further details contact your MSD Animal Health equine representative.
Last year Petplan received over 31,000 nominations across the five award categories: Practice of the Year, Vet of the Year, Vet Nurse of the Year, Practice Manager of the Year and Practice Support Staff of the Year.
The awards are judged by an independent panel which narrows the field to three finalists in each category, who are then invited to attend the awards ceremony.
The judges are looking for examples of exceptional levels of animal care, building and sustaining great relationships with colleagues and pet owners, and those who have gone above and beyond the call of duty.
James Barnes, Head of Sales & Partnerships at Petplan, said: “The Petplan Veterinary Awards provide the perfect opportunity to say thank you for the exceptional work carried out by members of the veterinary profession, whatever their field and wherever they’re based. The Petplan Vet Awards provide a great opportunity for both clients and colleagues to recognise the dedication and talent of veterinary professionals, teams and practices, right across the UK and say a particular thank you to those who have kept up the exceptional level of care even in the midst of a global crisis."
To nominate a colleague or your practice, visit www.petplan.co.uk before nominations close on 10th January 2022.
Louise is an RCVS and EBVS European Specialist in Veterinary Anaesthesia and Analgesia, and a Past President of the Pain Medicine Section Council at the Royal Society of Medicine. She has also been an invited examiner on the European Diploma examination and a Treasurer of the Association of Veterinary Anaesthetists. She has headed the anaesthesia team at Davies since 2007.
Her tips are:
The company says its new design is modular, allowing veterinary practices to customise kennels to their requirements now, and then upgrade them and add components as their needs change over time.
Options include dimmable daylight lighting or Casco Pet’s DRC Lighting System with three modes: Daylight (white), Recovery (red), and Cleaning (blue UVA), built-in thermostatically controlled heat mats, an illuminated glass whiteboard for easy recording and viewing of patient notes, integrated IV stand and pump holders, an internal ceiling vent and ventilation kit and an integrated plug socket and USB port .
Matthew Bubear, CEO, Casco Pet, said: “Our new generation of WellKennels, which have been designed to meet the dynamic demands of modern veterinary practices, allow practitioners to elevate the care they provide today while ensuring sustained adaptability for the needs of tomorrow."
WellKennels are certified by the International Society of Feline Medicine and are part of FearFree’s Preferred Product Program, the global initiative dedicated to preventing and alleviating fear, anxiety and stress in pets.
The new WellKennels will be unveiled at the London Vet Show, ExCel London, 16-17 November, on Stand H35.
https://cascopet.com/uk/products-and-services/veterinary
According to the RVC, recent studies estimate dental disease affects up to 18% of the UK's rabbits and breeds with lop ears and short skulls (brachycephaly) have long been suspected of being more at risk.
To investigate whether there is any truth to that suspicion, a team of RVC researchers led by Maria Jackson RVN, Research Assistant in Rabbit Health and Welfare, and Dr Charlotte Burn, Associate Professor in Animal Welfare and Behaviour Science, set out to explore whether these physical features are linked to dental problems.
The study involved visual dental checks of 435 volunteered pedigree rabbits from 49 breeds at British Rabbit Council shows and breeders’ studs across the UK.
The researchers assessed tooth and mouth health using an otoscope, while also recording ear type, head shape (on a purpose-made visual scale), body size, age and sex.
The findings revealed that:
In conclusion, the study concluded that diet, environment and regular dental checks might be more important in the development of dental disease.
The researchers also concluded that any breeding decisions should be based on veterinary assessment of dental health, including otoscope or radiography examinations rather than relying solely on visual inspection of the teeth or a rabbit’s conformation.
Maria said: “Our findings add to the evidence that suggests lop ears and a brachycephalic head shape are less important in the development of dental issues in rabbits than was once thought.
"It’s clear that all rabbits, not just those with a non-wild conformation, can be affected by dental problems.
“The importance of feeding good-quality hay or grass and supplementing the diet with extruded pellets, not muesli, cannot be overstated, as diet may well be more important than conformation in the development of dental disease.
"Likewise, providing regular veterinary dental check-ups to rabbits is crucial to facilitate early dental disease detection and give case-specific dietary and treatment recommendations to slow disease progression and support the welfare of rabbits.”
Photo: depositphotos.com
The changes are designed to make the process more accessible and the College says most were proposed as a result of candidate feedback. They are:
The changes will come into effect from 1 January 2025, in time for the 2025 Stat Exam cohort.
Dr Linda Prescott-Clements, RCVS Director of Education, said: “We have been listening to the concerns of various stakeholders, including those who have undertaken the Stat Exam previously and veterinary employers, and we used this feedback to work with the Department for Environment, Food & Rural Affairs (Defra) to come up with a set of practical, deliverable changes that improve the experience of Stat Exam for all candidates, and hopefully alleviate some of the stress involved around timescales, opportunity and finance.
“These changes will make the exam more accessible, as it will allow candidates to have two attempts at the written papers within the same diet, which need to be passed before being allowed to proceed to the practical exam and it will also help improve accessibility to the exam from the perspective of candidate finances.
www.rcvs.org.uk/statutory-membership-exam
Norbrook Laboratories has launched powder and paste versions of Noroquin - its glucosamine-based supplement range - for horses.
Noroquin contains the active ingredients glucosamine, chondrotin sulphate, manganese sulphate, zinc sulphate, absorbic acid and N-Acetyl-D-Glucosamine, designed to maintain healthy cartilage, promote joint management and keep horses mobile.
Michelle Jones, Brand Manager at Norbrook said: "In recent years, horses are increasingly competing longer which means maintaining the longevity of the horse is vitally important for long term success. 60% of lameness is related to osteoarthritis and is regarded as the major cause of disability in the athletic horse.
"With increasing reliability on nutritional supplements and concerns from horse owners about their aging horse, our Noroquin for Horses range can be offered as alternative to traditional pain management products indicated for musculoskeletal ailments or alongside them as a completely safe addition to a joint management programme."
Michelle added: "The Noroquin paste for horses is a highly palatable apple flavored paste that can be fed directly to the horse as a tasty treat and offers an alternative to traditional methods while the Noroquin powder for Horses is a highly palatable powder that can be mixed with food. The product is available in handy single-use sachets for accurate dosing and waterproof 1kg tubs."
Noroquin Powder and Paste for Horses joins the newly launched tasty tablets for dogs and cats and powder for cats in the Noroquin range. It is available from wholesalers.
Elanco Animal Health has highlighted the results of a new study1 which concludes that Duvaxyn IE-T Plus stimulates a highter protective antibody response than four other equine influenza vaccines commercially available in Ireland.
The trial compared the antibody responses of unvaccinated Thoroughbred weanlings following primary vaccination with Duvaxyn IE-T Plus, Equilis Resequin, Equip FT, Equilis Prequenza Te and ProteqFlu Te.
In addition, following the first vaccination, 43% of the weanlings failed to seroconvert. However, amongst those vaccinated with Duvaxyn IE-T Plus a 100% response rate was observed. The failure rate amongst vaccines other than Duvaxyn IE-T Plus ranged between 7.7% and 78.6%. By the time of the third vaccination (31 weeks after the first) all horses had responded to vaccination.
The study, conducted by the Irish Equine Centre in Johnstone, the Department of Life Sciences at the University of Limerick and the Department of Statistics at Trinity College in Dublin, involved 66 unvaccinated Thoroughbred weanlings on four different stud farms. Following primary vaccination (V1, V2 and V3) with the five vaccines antibody responses were monitored for six months post V3 by single radial haemolysis. Elanco says that the correlation between SRH antibody levels and protection has been well-established and accepted2.
Elanco also highlights a recent study3 which it says demonstrated the ability of Duvaxyn IE-T Plus equine influenza vaccine to cross protect against A/equi-2/Richmond/1/07 (H3N8) two weeks after a two dose primary course. The company says that this is believed to be the first demonstration of cross protection by a current UK equine influenza vaccine against a Florida sub-lineage clade 2 reference strain.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "Most studies carried out by vaccine companies take place under controlled conditions that are optimal for effective vaccination. This latest study shows how well Duvaxyn IET plus stimulates immunity under field conditions against both vaccinal and non-vaccinal strains. Importantly, all the weanlings vaccinated with Duvaxyn seroconverted after the first vaccination, conferring earliest and most reliable protection for these vulnerable animals."
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 779881.
References:
The awards are designed to recognise successful implementation of quality improvement (QI) in veterinary practice, which can reduce avoidable errors, ensure practice is based on the best available evidence and, ultimately, save lives.
Entrants will need to demonstrate the impact that QI methods have had in their practice, such as increased efficiency, improved clinical or financial effectiveness, the development of a culture of continuous improvement, support in the use of evidence-based approaches, or a general bettering of excellence in care.
The awards are open to any member of a practice, including veterinary surgeons and nurses, practice managers, receptionists, locums, students, and more. You can also nominate a colleague, or vice versa.
Individual winners will get free tickets to an upcoming RCVS Knowledge event and be given a plaque pronouncing them a 'Knowledge Champion', while one team will scoop Knowledge’s 'Champion Practice' award.
RCVS Knowledge Executive Director Chris Gush said: "These awards are a great opportunity to celebrate the good work that is going on in practice and to highlight examples of quality improvement.
"I would encourage all – from quality improvement experts to QI beginners – to get involved and enter the awards."
The closing date to submit an application is 1st November 2018, allowing plenty of time for those interested in introducing a quality improvement initiative in their practice to do so and apply for the awards at a later date.
To learn more about QI and how you can get started, visit RCVS Knowledge's QI pages.
Alternatively, you can enter the awards here: https://knowledge.rcvs.org.uk/grants/available-grants/
With at least 65% of dogs and 39% of cats reported as overweight (1&2), the competition is designed to promote a healthy body shape for cats and dogs, and reward the hard work of pet owners and veterinary nurses for achieving and maintaining a pet’s healthy weight. It is open to patients that are starting out on a weight loss programme, those maintaining a healthy body shape following weight loss and even those who have always been a healthy weight and shape.
Six finalists will be selected from all the entries and invited to attend an awards lunch where the overall winner will be announced. All finalists will receive a £100 shopping voucher and the overall winner will receive a £1000 holiday voucher.
Caroline Burke, Weight Management Specialist at Royal Canin said: "The Healthy Weight Competition is the perfect opportunity for veterinary nurses and owners to tackle this serious disease and prevent it occurring.
"There are many health issues associated with an animal being overweight as well as affecting quality of life, longevity and the welfare of the pet. The Healthy Weight Competition is an ideal opportunity for practices to identify the overweight patients, enrol them on a weight loss programme and enter the competition. It also enables them to reward those cats and dogs who have maintained an ideal body shape and weight over a period of time."
The competition is open until 31st of August 2018.
For more information, visit: www.royalcaninhealthyweight.co.uk or contact your Veterinary Business Manager.
Forte developed the new solution alongside Professor Gayle Hallowell, Professor of Veterinary Internal Medicine and Critical Care at the School of Veterinary Medicine and Science, University of Nottingham.
The company says Hydrafast delivers ideal levels of sodium and glucose. It also contains glycine, an amino acid, acetate, propionate and citrate.
Professor Hallowell said: “This new ORS formula for calves is both practical and research-based, and should address what we know calves need when they have diarrhoea. It provides nutrition as well as an optimal electrolyte balance.”
Hydrafast comes in sachets of 133g. Each box of Hydrafast contains 24 sachets.
Hydrafast is available now from all major veterinary wholesalers, or direct from Forte Healthcare Ltd.
For more information contact your Forte Territory Manager, email enquiries@fortehealthcare.com or visit: www.fortehealthcare.com/product/hydrafast/
Virbac has launched Prinovox, a new prescription-only spot-on ectoparasiticide for dogs and cats.
The company says the new product contains the same combination of Moxidectin and Imidacloprid as the market leader, but is offered with a unique and innovative pet owner engagement programme to help practices build loyalty, increase compliance and to encourage repeat purchase.
In dogs Prinovox is licensed for the treatment and prevention of lungworm; for the treatment and prevention of fleas and also for lice, mites, heartworm and roundworms. In cats, the licence covers fleas, mites, roundworm and heart worm. It can also be used for fleas and heartworm in ferrets.
Prinovox is available in six presentations to suit all weight ranges and in packs of four pipettes. The packaging uses the Blippar platform which owners can use to 'blip' interactive icons on the product's packaging with their smartphone to get more information on Prinovox, including a video on how to use it, a reminder system and a game.
In addition, the Prinovox support package includes:
Virbac's Head of Marketing Companion Animal, Simon Boulton MRCVS said: "We see the launch of Prinovox as a gamechanger. The ectoparasiticide market is one of the largest and most competitive in our industry and we are the first company to offer a product with the same efficacy as the market leader for all indications.
"We've gone one step further by increasing the value of the product to practices by developing a comprehensive parasite protection support package which harnesses the latest technology and consumer preferences for receiving information. We believe the efficacy of Prinovox, combined with the innovative support package we're offering, will make it a highly attractive product for practices and owners and we've been delighted at the feedback we've received so far."
Speakers include Prof. Jo Dukes McEwan, Head of Service, Professor in Small Animal Cardiology (University of Liverpool), Doctor Jennifer Schissler, Veterinary Dermatologist, Best Friends Animal Hospital & Urgent Care Unit (US), and Doctor Pascal Prélaud, Dermatologist, CEO ADVETIA Vet Hospital Center (France).
Participants will also be able to access to an immersive experience, the Vet Symposium Village, which includes the Live Stage, Vet Lab, Clinic Lounge, and Innovation Hub, all offering exclusive videos and lectures.
The event will be translated into Chinese, French, Spanish, Italian, Portuguese, Russian, and German, and a replay of the event will be available until the end of the year.
Dr. Jennifer Welser, Chief Medical Officer, Mars Veterinary Health, said: “It’s more critical than ever for pet professionals from various countries, fields, and perspectives to meet and share their knowledge.
"I look forward to participating in the Vet Symposium and speaking with my peers on topics ranging from mental health to advancements in quality medical care and retaining veterinary talent.”
https://digital-vetsymposium2022.com/
The 2-day Change Catalyst Veterinary Retreat will take place at Roaches Hall on the Derbyshire/Staffordshire border from 15-17th May 2018, after which participants will receive three months of personal one-to-one coaching.
The organisers say that during the retreat, which is provided in partnership with Natural Change, participants will take part in a series of largely outdoor activities that draw on the potential of nature. They will also be introduced to some simple nature-based techniques to look after their wellbeing and to reflect on their personal or professional journey. Post-retreat personal coaching is included to help reinforce and embed these changes or assist in developing the insights gained during the retreat.
The retreat is aimed at veterinary surgeons who are at a career crossroads, making major decisions about the direction of their career or for those looking for an opportunity to help develop capacity, build resilience and to improve wellbeing. The organisers say it offers time and space to get away from everyday concerns, re-energise and focus on what really matters as well as helping vets reflect, refresh and reconnect with nature.
The retreat is open to a maximum of 16 participants who will work with two facilitators. The follow up coaching is one to one, personal, and confidential.
Director, Adrian Nelson-Pratt said: "Vets have well documented challenges with work-life balance that lead to a disconnection from the natural world. Feelings of isolation, loss of career direction or in the worst-case, deterioration in physical and mental health can follow.
"Having experienced the Natural Change process myself, I found it a deeply reflective and restorative experience. It allowed me the time and space to develop some new ideas and to re-invigorate myself.
"The Change Catalyst Vet Retreat is the result of this process for me and I think it’s a powerful tool to support vets on a personal and professional level. It’s also an appropriate contribution to your annual CPD requirement."
Tickets cost £1500 and are available at https://www.emerge-veterinary.com/join-us/the-change-catalyst/ or for more information contact: adrian@emerge-veterinary.com
The modules, which are presented by US veterinary oncology specialists Dr Chad Johannes and Dr Sue Ettinger, are titled: ‘Mastering Mast Cell Tumours’, ‘Treating Canine Mast Cell Tumours’ and ‘Stelfonta’.
Each of the modules offer 30 minutes of bitesize, interactive CPD and are suitable for both veterinary surgeons and nurses.
Dr Neil Mottram MRCVS, Technical Product Manager at Virbac said: ‘We appreciate that for the majority of veterinary teams, finding time for CPD is pretty challenging at present. We therefore hope that the bitesize, on-demand format of these modules can provide the perfect solution, whilst still delivering high quality CPD’.
The modules can be accessed at: vet-uk.virbac.com/stelfonta/education
Virtual lunch and learn meetings are also available from Virbac Territory Managers.
For more information, speak to your Virbac Territory Manager, or visit vet-uk.virbac.com/stelfonta
Danilon is used to relieve the pain caused by musculoskeletal conditions, such as osteoarthritis (OA), bursitis, laminitis, and soft tissue inflammation.
Some oral NSAIDs have been shown to increase the risk of gastric irritation¹ - a particular concern when treating of chronic conditions.
However, Animalcare points to a study² in which horses given Danilon Gold showed a reduced number of ulcers and those that did appear were less severe.
The area of gastric mucosa affected was also five times less.
Animalcare says accurate administration is critical for clinical success.
To support this, Danilon Gold is presented in a coloured granule formulation and is now available in both 3g and 10g sachets.